• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad, March 9

Saamya Biotech (India) Ltd (SBIL) has signed a pact with the Indian Institute of Chemical Technology (IICT). Under the agreement, IICT would provide the SBIL with required facilities for the indigenisation of the technology the company got from its Italian collaborator, the Biofin Laboratories.

The Italian company had agreed to give technology to SBIL for the manufacture of some biopharmaceuticals involving microbial fermentations. "The pact with the IICT would help us save time in absorbing the Italian technology," Dr Y. Manivardhan Reddy, Managing Director of SBIL, said here in a press release.

More Stories on : Alliances & Joint Ventures | Bio-tech & Genetics

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Pepsi bottling plant in Vizag told not to use groundwater

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line